$ACB Melbourne-based Cann Group (ASX: CAN) has today announced the signing of a nationwide distribution deal with healthcare services and products supplier Symbion, as well as the first arrival of a high THC oil formulation shipment from strategic Canadian partner Aurora Cannabis (TSE:ACB). The Symbion deal will give Cann access to a network of more than 4,000 retail pharmacies and 1,300 hospitals throughout Australia, and the company will carry Cann's full range of imported products to supply Special Access Scheme (SAS) patients. Permits are also in place for the import and supply of an additional five product presentations being supplied by Aurora. In addition, the group notes it is well advanced in its product manufacturing validation program with IDT Australia with expectations to launch its first locally sourced and manufactured formulations in the first quarter of 2020.
  • 14
  • 3